Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About BAM Interactive Breakdown Better Bets vs. BAM Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Brookfield Asset Management (BAM)

Market Price (10/31/2025): $54.28 | Market Cap: $87.5 Bil
Sector: Financials | Industry: Asset Management & Custody Banks

Brookfield Asset Management (BAM)

Market Price (10/31/2025): $54.28
Market Cap: $87.5 Bil
Sector: Financials
Industry: Asset Management & Custody Banks

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 21%		  Expensive valuation multiples
P/SPrice/Sales ratio is 34x, P/EBITPrice/EBIT or Price/(Operating Income) ratio is 47x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 169x, P/EPrice/Earnings or Price/(Net Income) is 57x
1 Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 54%		  Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 237%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 20%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 20%		  
3 Low stock price volatility
Vol 12M is 34%		  
0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 21%
1 Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 54%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 20%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 20%
3 Low stock price volatility
Vol 12M is 34%
4 Expensive valuation multiples
P/SPrice/Sales ratio is 34x, P/EBITPrice/EBIT or Price/(Operating Income) ratio is 47x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 169x, P/EPrice/Earnings or Price/(Net Income) is 57x
5 Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 237%

Market Valuation & Key Metrics

BAMS&P 500
REVENUE GROWTHVERY GOOD
Rev LTM ($ Bil)2.5
Rev Chg Q33.9%6.4%
Rev Chg LTM21.4%5.4%
Rev Chg 3Y Avg1,197.0%5.3%
PROFITABILITYVERY GOOD
Op Inc LTM ($ Bil)1.4
CFO LTM ($ Bil)0.5
Net Inc LTM ($ Bil)1.5
Op Mgn LTM54.2%18.7%
CFO/Rev LTM20.3%20.4%
Net Inc Mgn60.1%12.8%
VALUATIONVERY HIGH
P/S34.73.2
P/CFO171.015.5
P/FCF171.020.6
P/E57.723.6

BAM Stock

   
   
   
   
   
   
   
Factor Drivers of Stock Movement
The 2.3% change in BAM stock from 5/1/2025 to 10/30/2025 was primarily driven by a 224.3% change in the company's P/E Multiple.

501202510302025Change
Stock Price ($)52.4453.672.34%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)2169.002522.0016.27%
Net Income Margin (%)57.68%60.11%4.22%
P/E Multiple17.6057.09224.33%
Shares Outstanding (Mil)419.901612.60-284.04%
Cumulative Contribution-823.36%

LTM = Last Twelve Months as of date shown
The 2.8% change in BAM stock from 10/30/2024 to 10/30/2025 was primarily driven by a 21.4% change in the company's Total Revenues ($ Mil).

1030202410302025Change
Stock Price ($)52.2353.672.75%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)2077.002522.0021.43%
Net Income Margin (%)55.51%60.11%8.28%
P/E Multiple72.6257.09-21.39%
Shares Outstanding (Mil)1603.101612.60-0.59%
Cumulative Contribution2.75%

LTM = Last Twelve Months as of date shown
null

null

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
BAM Return---46%40%1%109%
Peers Return18%14%-11%8%1%0%32%
S&P 500 Return16%27%-19%24%23%16%110%

Monthly Win Rates [3]
BAM Win Rate-- 67%67%44% 
Peers Win Rate50%40%28%45%38%38% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
BAM Max Drawdown----1%-6%-20% 
Peers Max Drawdown-31%-10%-25%-9%-9%-13% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: VRTS, SLRC, DHIL, GEG, FGNX.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

Unique KeyEventBAMS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-20.5%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven25.7%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven31 days464 days

Compare to VRTS, SLRC, DHIL, GEG, FGNX


In The Past

Brookfield Asset Management's stock fell -20.5% during the 2022 Inflation Shock from a high on 9/15/2023. A -20.5% loss requires a 25.7% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Brookfield Asset Management (BAM)

Better Bets than Brookfield Asset Management (BAM)

 BAMBetter Performance than BAM
MetricValueIndustry (Asset Management & Custody Ban)
Rev Chg LTM21.4%BX (34.9%), ARES (49.9%), CG (133.3%), OWL (31.8%), TPG (27.3%)
Op Mgn LTM54.2%SWKH (60.3%)
CFO/Rev LTM20.3%BX (29.2%), KKR (29.7%), BK (20.3%), AMP (39.0%), ARES (84.1%)
FCF/Rev LTM20.3%BX (28.3%), KKR (28.6%), AMP (38.0%), ARES (82.4%), NTRS (22.4%)
Total Yield2.7%BLK (5.6%), BX (7.0%), BK (8.3%), APO (6.2%), AMP (8.6%)
 BAMBetter Performance than BAM
MetricValueAll Other Sectors
Rev Chg LTM21.4%NVDA (71.6%), AVGO (28.0%), LLY (36.8%), PLTR (38.8%), AMD (27.2%)
Op Mgn LTM54.2%NVDA (58.1%), APP (55.6%), MO (59.0%), FNV (68.3%), VICI (92.8%)
CFO/Rev LTM20.3%NVDA (46.6%), AAPL (26.6%), MSFT (50.0%), GOOGL (39.3%), AVGO (42.4%)
FCF/Rev LTM20.3%NVDA (43.6%), AAPL (23.5%), MSFT (26.6%), AVGO (41.6%), META (23.7%)
Total Yield2.7%AAPL (2.8%), MSFT (3.3%), GOOGL (3.9%), AMZN (3.0%), META (3.8%)
 Best Bets In Financials Sector
 BAMDBRG OTF MTG NMIH CACC ENVA FNF ACGL APAM FI
What You Pay           
P/E57.139.713.28.47.512.310.213.98.610.510.6
P/EBIT47.364.79.06.45.59.97.88.97.66.15.8
What You Get           
Rev Chg Q33.9%-102.4%1,228.5%-0.7%7.2%8.3%16.3%16.8%22.4%4.4%8.0%
Rev Chg LTM21.4%-84.8%89.0%2.2%10.0%12.5%21.1%7.4%23.5%10.0%6.7%
Rev Chg 3Y Avg�125.8%221.9%1.2%10.1%6.9%23.5%-0.7%29.8%0.2%7.5%
FCF/Rev 3Y Avg56.8%101.2%76.2%62.2%58.8%57.1%54.7%50.8%38.4%29.0%20.7%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 21%, alpha of 9.1%, and sharpe of 0.94

Latest Trefis Analyses

Trade Ideas

Select past ideas related to BAM. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield09302025HLNEHamilton LaneDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-14.4%-14.4%-14.4%
CNS_9302025_Dip_Buyer_ValueBuy09302025CNSCohen & SteersDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.9%5.9%-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025JKHYJack Henry & AssociatesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		0.3%0.3%-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025FDSFactSet Research SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-7.7%-7.7%-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%09052025IBKRInteractive BrokersQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		15.0%15.0%0.0%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield09302025HLNEHamilton LaneDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-14.4%-14.4%-14.4%
CNS_9302025_Dip_Buyer_ValueBuy09302025CNSCohen & SteersDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.9%5.9%-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025JKHYJack Henry & AssociatesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		0.3%0.3%-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025FDSFactSet Research SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-7.7%-7.7%-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%09052025IBKRInteractive BrokersQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		15.0%15.0%0.0%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines279.1%161.2%
2INBXInhibrx Biosciences131.0%409.8%
3PUMPProPetro99.6%16.2%
4DYNDyne Therapeutics88.4%-0.0%
5VICRVicor85.4%89.2%
6CELCCelcuity74.6%503.2%
7GLUEMonte Rosa Therapeutics73.5%87.5%
8NVTSNavitas Semiconductor72.1%251.8%
9LUMNLumen Technologies70.3%94.7%
10BALYBallys63.4%4.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-62.9%5106.3%
2LRNStride-53.8%-35.8%
3FMCFMC-51.0%-66.6%
4FIFiserv-48.3%-68.3%
5NFENew Fortress Energy-43.6%-91.9%
6VGVenture Global-41.7% 
7OGNOrganon-40.2%-55.0%
8VRNSVaronis Systems-39.5%-21.2%
9ITGRInteger-38.5%-52.2%
10LENZLENZ Therapeutics-37.9%5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Brookfield Asset Management

Financials

BAMVRTSSLRCDHILGEGFGNXMedian
NameBrookfie.Virtus I.SLR Inve.Diamond .Great ElmFG Nexus  
Mkt Price53.67163.2115.23126.292.503.6534.45
Mkt Cap86.51.10.80.30.1-0.8
Rev LTM2,522885981531612125
Op Inc LTM1,368182-44-8-113
FCF LTM51231162-9-9-414
FCF 3Y Avg5071283624-10-630
CFO LTM51238162-6-9-417
CFO 3Y Avg5081353625-9-630

Growth & Margins

BAMVRTSSLRCDHILGEGFGNXMedian
NameBrookfie.Virtus I.SLR Inve.Diamond .Great ElmFG Nexus  
Rev Chg LTM21.4%0.9%-12.1%6.8%-8.5%-41.5%-3.8%
Rev Chg 3Y Avg--3.1%135.6%-4.6%13.5%80.0%13.5%
Rev Chg Q33.9%-6.2%3.4%-0.1%-37.1%73.2%1.6%
QoQ Delta Rev Chg LTM13.1%-1.5%0.9%-0.0%-16.9%47.7%0.4%
Op Mgn LTM54.2%20.6%-29.0%-49.1%-24.8%
Op Mgn 3Y Avg37.9%18.9%-28.2%-74.1%-23.6%
QoQ Delta Op Mgn LTM-5.4%0.4%--2.8%-6.5%--4.1%
CFO/Rev LTM20.3%4.3%165.8%-3.9%-55.2%-33.1%0.2%
CFO/Rev 3Y Avg57.7%16.0%12.7%17.2%-56.6%-34.5%14.4%
FCF/Rev LTM20.3%3.6%165.8%-5.6%-55.2%-33.5%-1.0%
FCF/Rev 3Y Avg56.8%15.2%12.7%16.6%-66.7%-35.0%14.0%

Valuation

BAMVRTSSLRCDHILGEGFGNXMedian
NameBrookfie.Virtus I.SLR Inve.Diamond .Great ElmFG Nexus  
Mkt Cap86.51.10.80.30.1-0.8
P/S34.31.38.52.24.1-4.1
P/EBIT47.32.9-7.83.4-5.6
P/E57.17.79.47.25.2-7.7
P/CFO169.029.25.1-57.0-7.4-5.1
Total Yield2.7%18.6%21.5%18.7%19.4%-18.7%
Dividend Yield0.9%5.6%10.8%4.8%0.0%-4.8%
FCF Yield 3Y Avg0.9%8.6%3.5%5.4%-17.7%-3.5%
D/E0.02.11.40.00.9-0.9
Net D/E0.01.91.0-0.1-0.7-0.0

Returns

BAMVRTSSLRCDHILGEGFGNXMedian
NameBrookfie.Virtus I.SLR Inve.Diamond .Great ElmFG Nexus  
1M Rtn-5.7%-14.1%-0.4%-9.8%2.0%-33.5%-7.8%
3M Rtn-12.3%-15.6%-2.4%-5.9%21.4%--5.9%
6M Rtn2.3%5.5%4.5%0.2%30.9%-4.5%
12M Rtn2.8%-24.2%8.9%-15.3%38.9%-2.8%
3Y Rtn-5.9%52.8%-19.9%22.5%-14.2%
1M Excs Rtn-5.4%-13.9%-0.9%-11.1%0.8%-40.1%-8.3%
3M Excs Rtn-19.0%-23.3%-11.1%-13.7%8.6%--13.7%
6M Excs Rtn-19.4%-16.2%-17.2%-21.5%9.2%--17.2%
12M Excs Rtn-13.6%-41.3%-9.2%-33.4%28.2%--13.6%
3Y Excs Rtn--69.9%-23.8%-96.9%-51.8%--60.8%

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date8/8/20255/9/20253/17/202511/12/20248/9/20245/8/20243/19/202411/9/20238/14/20235/15/20234/3/202311/15/2022
Key Financials Quarterly            
Total Revenue1,1531,0791201708611,01816038470-794831
Net Income62058118612949544195122109125-376395
EPS0.380.360.420.310.310.280.230.310.280.31-0.950.98
Key Financials TTM            
Total Revenue TTM2,5222,2302,1692,2092,0771,263245-70984---
Net Income TTM1,5161,3911,2511,1601,153767451-20253---
Growth Rates Quarterly            
Total Revenue Growth33.9%6.0%-25.0%347.4%1731.9%-120.2%-95.4%----
Net Income Growth25.3%31.7%95.8%5.7%354.1%252.8%125.3%-69.1%----
Margins Quarterly            
Net Income Margin53.8%53.8%155.0%75.9%57.5%43.3%59.4%321.1%231.9%--47.5%
Cash & Debt            
Total Cash48033212161099121212-0
Total Debt1,250639219210002561891249500
Net Debt / (Cash)770307207194-10-924717711283--0
Cash Flows Quarterly            
FCF from Operations529265-849567393516-586599134-41-2,0792,077
Cash Flows TTM            
FCF from Operations TTM512376627890922663106-1,38791---
Returns to Shareholders Quarterly            
Dividends702707-1,229620619620-1,071524127528-180180
Share Repurchases-0116-0-0-0-0319-036-0-1,1401,418
Return on Invested Capital (ROIC) Quarterly            
ROIC20.9%27.3%3.0%3.0%64.0%79.7%-4.0%1.4%2.2%-0.8%--
Return on Invested Capital (ROIC) TTM            
ROIC TTM13.7%14.1%37.9%37.0%39.5%23.7%-0.3%-28.0%0.4%---

Price Behavior

BAM Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta1.922.002.201.111.23-0.08
Up Beta4.153.012.441.011.02-0.08
Down Beta2.821.461.520.971.260.14
Up Capture35%108%201%151%185%172%
Bmk +ve Days13233574144420
Stock +ve Days10203065132362
Down Capture279%259%263%137%124%104%
Bmk -ve Days8192952107330
Stock -ve Days11223459117331

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity14,649,753
Short Interest: % Change Since 93020254.0%
Average Daily Volume1,593,407
Days-to-Cover Short Interest9.19
Basic Shares Quantity1,612,600,000
Short % of Basic Shares0.9%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/6/20252.3%1.8%-3.4%
5/6/20252.1%6.6%5.8%
2/12/2025-1.0%9.1%-17.4%
SUMMARY STATS   
# Positive231
# Negative102
Median Positive2.2%6.6%5.8%
Median Negative-1.0% -10.4%
Max Positive2.3%9.1%5.8%
Max Negative-1.0% -17.4%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025808202510-Q 6/30/2025
3312025509202510-Q 3/31/2025
12312024317202510-K 12/31/2024
9302024111220246-K 9/30/2024
630202480920246-K 6/30/2024
331202450820246-K 3/31/2024
12312023319202440-F 12/31/2023
9302023110920236-K 9/30/2023
630202381420236-K 6/30/2023
331202351520236-K 3/31/2023
12312022403202320-F 12/31/2022

Insider Activity

Expand for More

 

Industry Resources

External Quote Links


Prefer one of these to Trefis? Tell us why.